Colonial Trust’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$180 Hold
30
﹤0.01% 1126
2025
Q4
$215 Hold
30
﹤0.01% 1077
2025
Q3
$320 Hold
30
﹤0.01% 1064
2025
Q2
$290 Hold
30
﹤0.01% 1075
2025
Q1
$447 Sell
30
-64
-68% -$984 ﹤0.01% 1049
2024
Q4
$1.4K Sell
94
-162
-63% -$2.64K ﹤0.01% 1243
2024
Q3
$4.9K Buy
256
+142
+125% +$2.94K ﹤0.01% 878
2024
Q2
$2.36K Hold
114
﹤0.01% 926
2024
Q1
$2.14K Sell
114
-49
-30% -$841 ﹤0.01% 928
2023
Q4
$2.35K Sell
163
-9
-5% -$122 ﹤0.01% 886
2023
Q3
$2.99K Hold
172
﹤0.01% 854
2023
Q2
$3.58K Buy
172
+55
+47% +$1.2K ﹤0.01% 826
2023
Q1
$2.75K Hold
117
﹤0.01% 818
2022
Q4
$3.27K Buy
+117
New +$2.99K ﹤0.01% 810

Other funds holding OGN

Colonial Trust's OGN Position: Q1 2026 in Review

Colonial Trust held its Organon & Co (OGN) position steady in Q1 2026 at 30 shares worth $180. The position accounts for ﹤0.01% of the portfolio, ranked #1126.

Colonial Trust first reported a position in OGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $4.9K in Q3 2024. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Colonial Trust held 30 shares of Organon & Co worth $180 as of Q1 2026.
  • Colonial Trust left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Colonial Trust's portfolio in Q1 2026, its #1126 holding.
  • Colonial Trust first reported a position in Organon & Co in Q4 2022 and has held it in 14 quarters since.
  • Colonial Trust's Organon & Co position peaked at $4.9K in Q3 2024.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Colonial Trust's 13F filing for Q1 2026, filed 12 May 2026.